Micell Technologies is a biomedical device company developing interventional cardiology systems for vascular drug delivery.
Micell Technologies, Inc., a biomedical device company, develops interventional cardiology systems for vascular drug delivery. It develops MiStent, a drug-eluting stent that allows control of drug release and pharmacokinetics. The company was founded in 1995 and is based in Raleigh, North Carolina.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Oct 1, 2009 | Series B | $15M | 1 | — | — | Detail |
Jul 12, 2007 | Series A | $7M | 1 | Invemed Catalyst Fund | — | Detail |
Jul 18, 2002 | Series Unknown | $1M | 2 | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Invemed Catalyst Fund | — | Series B |
Gladwyne Partners | — | Series Unknown |